Enzo Biochem: Hamid Erfanian, Elazar Rabbani

Enzo Biochem has appointed Hamid Erfanian as its CEO. Elazar Rabbani, the firm's outgoing CEO, remains chairperson of the board of directors and will assume the role of chief scientific officer.

Erfanian was most recently chief commercial officer of PerkinElmer's Euroimmun. From June 2014 to Aug. 2021, he was CEO of Euroimmun's US subsidiary. Prior to Euroimmun, Erfanian held executive and senior positions at several diagnostics companies including Diagnostica Stago, Beckman Coulter, and Abbott Laboratories. Earlier in his career, he worked at Quest Diagnostics and Laboratory Corporation of America.